01. Mesothelioma Care
Mesothelioma Care at University of Michigan
The University of Michigan treats cancer patients, including those with mesothelioma, at the Rogel Cancer Center. Mesothelioma is treated through their Thoracic Oncology Program, which is also where they conduct research in an effort to find more effective treatments.
Within this program is a team of thoracic surgeons, medical oncologists, radiation oncologists, pulmonologists, gastroenterologists, radiologists, pathologists and nurses. The multidisciplinary team works to provide each patient with a personalized treatment plan, consisting commonly of surgery, radiation and chemotherapy.
Rogel Cancer Center also practices the use of heated intraperitoneal chemotherapy (HIPEC), a heated chemotherapy wash, in the treatment of peritoneal mesothelioma. For patients interested in experimental treatments for mesothelioma, clinical trials are offered through the University of Michigan Cancer Center for those who are eligible.
If patients choose to receive care from UM Rogel Cancer Center, they can utilize a variety of resources. There is a patient assistance center that helps families with everything from exploring financial assistance options to lodging and parking. They also offer complementary therapies to help patients on their treatment journey, including art therapy and guided imagery therapy.
University of Michigan Specializations
- Lung cancer
- Peritoneal mesothelioma
- Pleural mesothelioma
University of Michigan Accreditations
- Blue Distinction Center for Complex and Rare Cancers designation
- Commission on Cancer of the American College of Surgeons accreditation
- Joint Commission accreditation
- Michigan Cancer Consortium member
- National Cancer Institute Comprehensive Cancer Center designation
- National Comprehensive Cancer Network member
- Oncology Care Model designation
- The Quality Oncology Practice Initiative recognition
04. Mesothelioma Clinical Trials
Mesothelioma Clinical Trials at University of Michigan
The following clinical trials are in progress or actively recruiting participants at University of Michigan:
Conditions: Carcinoma, Neoplasms, Carcinoma, Squamous Cell, Adenocarcinoma, Neoplasms, Germ Cell and Embryonal, Mesothelioma, Nasopharyngeal Carcinoma, Cholangiocarcinoma, Carcinoma, Basal Cell, Gastrointestinal Stromal Tumors, Carcinoid Tumor, Carcinoma, Transitional Cell, Carcinoma, Adenoid Cystic, Teratoma, Adenocarcinoma of Lung, Carcinoma, Neuroendocrine, Pheochromocytoma, Seminoma, Choriocarcinoma, Cystadenocarcinoma, Serous, Cystadenocarcinoma, Carcinoma, Endometrioid, Paraganglioma, Chordoma, Hemangiosarcoma, Fibromatosis, Aggressive, Adenocarcinoma, Clear Cell, Adenocarcinoma, Mucinous, Trophoblastic Neoplasms, Gestational Trophoblastic Disease, Nerve Sheath Neoplasms, Neurofibrosarcoma, Thyroid Neoplasms, Fibroma, Cystadenocarcinoma, Mucinous, Pseudomyxoma Peritonei, Vulvar Neoplasms, Sex Cord-Gonadal Stromal Tumors, Adrenocortical Carcinoma, Carcinoma, Islet Cell, Paget Disease, Extramammary, Adenocarcinoma, Papillary, Carcinoma, Acinar Cell, Adenocarcinoma, Bronchiolo-Alveolar, Mixed Tumor, Mullerian, Neoplasms, Unknown Primary, Carcinoma, Giant Cell
Last Updated: April 3, 2021